Prevention for Chemotherapy-induce Phlebitis with tropical extract Oil
Article Sidebar
Main Article Content
Abstract
Chemotherapy-induced phlebitis (CIP) is a significant complication for cancer patients. CIP can develop as an acute phase within 24 hours after chemotherapy and is commonly observed during the second dose. The incidence of CIP is high not only in Thailand but also in other countries. In Thailand, CIP is often detected in cancer patients between the 3rd and 4th days of the chemotherapy cycle. CIP can affect patients physically, mentally, and socioeconomically. This article serves as a resource for nurses in preventing chemotherapy-induced phlebitis, exploring the potential use of various essential oils, including sesame oil, Nigella sativa extract oil, and chamomile oil, for topical application on the skin overlying the veins used for drug administration. It represents the application of evidence-based knowledge aimed at enhancing cancer patient care and reducing the incidence of chemotherapy-induced phlebitis.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
เนื้อหาและข้อมูลในบทความที่ลงตีพิมพ์ในวชิรสารการพยาบาลถือเป็นข้อคิดเห็นและความรับผิดชอบของผู้เขียนบทความโดยตรง ซึ่งกองบรรณาธิการไม่จำเป็นต้องเห็นด้วย หรือร่วมรับผิดชอบใด ๆ ทั้งสิ้น
บทความ ข้อมูล เนื้อหา รูปภาพ ฯลฯ ที่ได้รับการตีพิมพ์ในวชิรสารการพยาบาล ถือเป็นลิขสิทธิ์ของวชิรสารการพยาบาล หากบุคคลใดหรือหน่วยงานใดต้องการนำทั้งหมดหรือส่วนหนึ่งส่วนใดไปเผยแพร่ต่อหรือเพื่อกระทำการใด ๆ จะต้องได้รับอนุญาตเป็นลายลักอักษรจากวชิรสารการพยาบาลก่อนเท่านั้น
References
Elflein J. Predicted number of new cancer cases worldwide from 2020 to 2040. 2022.
World health Organization. The global cancer observatory. 2020 May10, 2022.
Wang L, Lankhorst L, Bernards R. Exploiting senescence for the treatment of cancer. Nature Reviews Cancer. 2022;22(6):340-355.
National Cancer Institute. Hospital-Based Cancer Registry 2021. 2022.
Harris V, Hughes M, Roberts R, Dolan G, Williams EM. The Development and Testing of a Chemotherapy-Induced Phlebitis Severity (CIPS) Scale for Patients Receiving Anthracycline Chemotherapy for Breast Cancer. Journal of Clinical medicine. 2020;9(3):1-2.
Han J, Owji S, Agarwal A, Kamat S, Luu Y, Mubasher A, et al. Bortezomib-Induced Reticular Eruption in Patient with Multiple Myeloma. Dermatopathology (Basel). 2023;10(3):226-230.
Behnamfar N, Yekta ZP, Mojab F, Naeini SMK. The effect of nigella sativa oil on the prevention of phlebitis induced by chemotherapy: a clinical trial. BioMedicine. 2019;9(3):32-38.
Goulart CB, Custodio CS, Vasques CI, Ferreira EB, Diniz dos Reis PE. Effectiveness of topical interventions to prevent or treat intravenous therapy-related phlebitis: A systematic review. Journal of Clinical Nursing. 2020;29(13-14):2138-2149.
Vorakitticharoon T, Vuttanon N, Srirat C, Vichittrakoonthavon S. Effect of the Supportive-Educative Nursing Program on PhlebitisOccurrence among Cancer Patients Receiving Chemotherapy. Kuakarun Journal of Nursing. 2024; 31(1):1-14.
Macklin D. Phlebitis: A painful complication of peripheral IV catheterization that may be prevented. The American Journal of Nursing. 2003;103(2):55-60.
Mielke N, Johnson S, Karabon P, Bahl A. A prospective sonographic evaluation of peripheral intravenous catheter associated thrombophlebitis. The Journal of Vascular Access. 2022;23(5):754-763.
Sudhakar S, Jacob A, Hegde NN, Chaudhary RK, Mateti UV, Shetty V. Evaluation of chemotherapy infusion and phlebitis among cancer patients: A prospective observational single-center study. Journal of Oncology Pharmacy Practice. 2023;29(8):1944-1950.
Akyurek FT, Sari N, Ugurluoglu C, Kurtipek GS. Serpentine supravenous hyperpigmentation related to carboplatin and vinorelbine chemotherapy: A case report. Dermatologic Therapy Journal. 2019;32(4):e12981.
Evangelos T, Abdulazeez S. Improving the frequency of visual infusion phlebitis (VIP) scoring on an oncology ward. BMJ Quality Improvement Reports. 2014;3(1):1-2.
Niedzwiedz CL, Knifton L, Robb KA, Katikireddi SV, Smith DJ. Depression and anxiety among people living with and beyond cancer: a growing clinical and research priority. BMC Cancer Journal. 2019;19(1):1-8.
Thasaneesuwan S, Nilmanat K. Psychological Distress in Patient with Cancer Undergoing Chemotherapy and Nursing Care. Songklanagarind Journal of Nursing. 2019;39(4):110-119.
Prapai Chengtawee, Suwannee Sirilerttrakul. Factors Related to Depressive Episode among the Colorectal Cancer Patients Receiving hemotherapy: A Case Study at Oncology Unit, Ramathibodi Hospital. Srinagarind Medical Jounal. 2017;32(1): 63-70.
Nekuzad N, Ashke Torab T, Mojab F, Alavi-Majd H, Azadeh P, Ehtejab G. Effect of external use of sesame oil in the prevention of chemotherapy-induced phlebitis. Iranian Journal of Pharmaceutical Research. 2012;11(4):1065-1071.
Shamloo MBB, Nasiri M, Maneiy M, Dorchin M, Mojab F, Bahrami H, et al. Effects of topical sesame (Sesamum indicum) oil on the pain severity of chemotherapy-induced phlebitis in patients with colorectal cancer: A randomized controlled trial. Complementary Therapies in Clinical Practice. 2019;35:78-85.
Safikani Mohammadzadeh N, Elahi N, Molavynejad S, Maraghi E, Ehsanpor A. Comparing the Effects of Sesame Oil vs. Nitroglycerin Ointment on the Incidence of Chemotherapy-Induced Phlebitis: A Single Blind Clinical Trial. Asian Pacific Journal of cancer Prevention. 2023; 24(4):1113-1117.
Maleki M, Mardani A, Manouchehri M, Ashghali Farahani M, Vaismoradi M, Glarcher M. Effect of Chamomile on the Complications of Cancer: A Systematic Review. Integrative Cancer Therapies. 2023;22:1-13.
Reis PE, Carvalho EC, Bueno PC, Bastos JK. Clinical application of Chamomilla recutita in phlebitis: dose response curve study. Revista Latino-Americana de Enfermagem. 2011;19(1):3-10.
